MedTrace Logo

Nutrient Levels Alter Transplant Outcome

NCT00560014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2007-11-19

No results posted yet for this study

Summary

The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.

Conditions

  • Chronic Renal Disease

Interventions

DIETARY_SUPPLEMENT

Arginine and canola oil

Canola oil 1 tablespoon BID Arginine 9.0grams BID

DIETARY_SUPPLEMENT

Coromega and Arginine

Arginine 9.0 grams BID Coromega dose based on weight

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • J. W. Alexander, M.D. · UC Surgeons Center fo Surgical Weight Loss/ University of Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00560014 on ClinicalTrials.gov